North American Veterinary Licensing Examination (NAVLE) Practice Test

In feline leukemia virus (FeLV) seropositive cats that develop lymphoma, treatment response is similar to that of seronegative cats. This indicates that regardless of their FeLV status, both seropositive and seronegative cats can have comparable outcomes when it comes to how well they respond to lymphoma therapies.

Lymphoma in cats is influenced by various factors, including the type and stage of cancer, the overall health of the cat, and the specific treatments used. Therefore, the effectiveness of treatment may resemble one another across different FeLV status groups.

In contrast, factors such as remission rates, prevalence of gastrointestinal lymphoma, and prevalence of mediastinal lymphoma can vary between seropositive and seronegative cats due to the systemic effects of the viral infection and related immune response implications. FeLV can influence the type of lymphoma that develops and its presentation, which is why these aspects do not share the same consistency between the two groups.